Wolff D J, Datto G A, Samatovicz R A
Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.
J Biol Chem. 1993 May 5;268(13):9430-6.
The antifungal imidazoles miconazole, ketoconazole, and clotrimazole inhibit citrulline formation by nitric-oxide synthase. These agents both increase the concentration of calmodulin required to activate the enzyme half-maximally and reduce the maximal velocity of citrulline formation. This inhibition was not reversed by increased concentrations of either the arginine substrate or (6R)-5,6,7,8-tetrahydro-L-biopterin. Miconazole, ketoconazole, and clotrimazole also inhibited the cytochrome-c reductase activity of nitric-oxide synthase competitively versus calmodulin concentration, with apparent Ki (IC50) values of 8, 20, and 0.8 microM, respectively. Miconazole, ketoconazole, and clotrimazole inhibited the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase competitively versus calmodulin concentration, with apparent Ki values of 6, 18, and 25 microM, respectively. These observations are consistent with the proposal that the antifungal imidazoles inhibit citrulline formation by interaction with the nitric-oxide synthase at two sites. Interaction at site 1 reduces the responsiveness of the enzyme to activation by calmodulin, whereas interaction at site 2 (involving putative binding of the imidazole to the heme iron) reduces the maximal velocity of citrulline formation. The interactions of calmodulin antagonists at site 1 occur at substantially lower concentrations of drug than those at site 2 and are the principal determinant of enzyme inhibition.
抗真菌咪唑类药物咪康唑、酮康唑和克霉唑可抑制一氧化氮合酶生成瓜氨酸。这些药物既增加了使该酶达到最大激活程度所需的钙调蛋白浓度,又降低了瓜氨酸生成的最大速度。增加精氨酸底物或(6R)-5,6,7,8-四氢-L-生物蝶呤的浓度并不能逆转这种抑制作用。咪康唑、酮康唑和克霉唑还对钙调蛋白浓度竞争性地抑制一氧化氮合酶的细胞色素c还原酶活性,其表观Ki(IC50)值分别为8、20和0.8微摩尔。咪康唑、酮康唑和克霉唑对钙调蛋白浓度竞争性地抑制钙调蛋白依赖性环核苷酸磷酸二酯酶的活性,其表观Ki值分别为6、18和25微摩尔。这些观察结果与以下观点一致:抗真菌咪唑类药物通过在两个位点与一氧化氮合酶相互作用来抑制瓜氨酸的生成。在位点1的相互作用降低了酶对钙调蛋白激活的反应性,而在位点2的相互作用(涉及咪唑与血红素铁的假定结合)降低了瓜氨酸生成的最大速度。钙调蛋白拮抗剂在位点1的相互作用发生时的药物浓度远低于在位点2的浓度,并且是酶抑制的主要决定因素。